Life Sciences and Emerging Growth Businesses — Segment assets

Corning Life Sciences and Emerging Growth Businesses — Segment assets decreased by 3.2% to $1.42B in Q1 2026 compared to the prior quarter.

Analysis

StatementSegment

CategoryEfficiency

SignalContext dependent

VolatilityStable

First reportedQ4 2025

Last reportedQ1 2026May 1, 2026

Rolls up toAssets Net

How to read this metric

An increase indicates asset growth or expansion, while a decrease may suggest asset optimization or divestiture.

Detailed definition

This metric measures the total value of assets directly attributable to the Life Sciences and Emerging Growth segment, i...

Peer comparison

Comparable to segment asset reporting in diversified manufacturing firms.

Metric ID: glw_segment_life_sciences_and_emerging_growth_businesses_segment_assets

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$1.47B	$1.42B
QoQ Change	—	-3.2%

Range$1.42B – $1.47B

Similar Metrics at Other Companies

Thermo Fisher ScientificTMO View metric

DanaherDHR View metric

Agilent TechnologiesA View metric

STERISSTE View metric

Thermo Fisher ScientificTMO View metric

Frequently Asked Questions

What is Corning's life sciences and emerging growth businesses — segment assets?: Corning (GLW) reported life sciences and emerging growth businesses — segment assets of $1.42B in Q1 2026.
What does life sciences and emerging growth businesses — segment assets mean?: The total value of assets used by the Life Sciences and Emerging Growth segment.